Search
for

    GlossaryHirsutism Treatment

    medical and cosmetic methods to reduce excessive female hair growth

    Hirsutism Treatment refers to the medical and cosmetic interventions used to manage excessive hair growth in women, typically in areas where men usually grow hair, such as the face, chest, and back. This condition is often caused by hormonal imbalances, and treatments can include medications like anti-androgens, oral contraceptives, and topical creams, as well as procedures like laser hair removal and electrolysis.

    Related Terms

    Learn

    5 / 5 results

      learn Bicalutamide

      a nonsteroidal anti-androgen, most commonly used orally for women

      learn Spironolactone

      powerful topical and oral anti-androgen used mostly by women

      learn Cyproterone

      a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

      learn RU58841

      a potent but unapproved and potentially problematic topical anti-androgen

    Research

    5 / 1000+ results

    Community Join

    5 / 25 results

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  35 upvotes 5 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  118 upvotes 3 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Spironolactone or bicalutamide prescription

      in Treatment  4 upvotes 1 year ago
      The conversation is about someone seeking a doctor in the EU who prescribes spironolactone or bicalutamide for female pattern hair loss, as they are having difficulty finding treatment options beyond Minoxidil in Austria. They are asking for recommendations and are open to direct messages for assistance.